Insider: Tanguler Tolga EVP, Chief Commercial Officer - ALNYLAM PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 29,271 | 0 | 29,271 |
| Value | $13,066,574.40 | $0.00 | $13,066,574.40 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/29/2025 | DDS | 195 | Direct | COM | $445.53 | $86,878.35 | 29,271 |
| 08/29/2025 | DDS | 144 | Direct | COM | $452.49 | $65,158.56 | 25,992 |
| 08/29/2025 | DDS | 1,289 | Direct | COM | $448.05 | $577,536.45 | 27,083 |
| 08/29/2025 | DDS | 899 | Direct | COM | $446.98 | $401,835.02 | 28,372 |
| 08/29/2025 | DDS | 681 | Direct | COM | $449.54 | $306,136.74 | 26,402 |
| 08/29/2025 | DDS | 266 | Direct | COM | $451.52 | $120,104.32 | 26,136 |
| 08/18/2025 | DDS | 39 | Direct | COM | $450.92 | $17,585.88 | 30,694 |
| 08/18/2025 | DDS | 90 | Direct | COM | $449.92 | $40,492.80 | 30,733 |
| 08/18/2025 | DDS | 39 | Direct | COM | $447.98 | $17,471.22 | 30,823 |
| 08/18/2025 | DDS | 103 | Direct | COM | $451.99 | $46,554.97 | 30,591 |
| 08/18/2025 | DDS | 241 | Direct | COM | $454.84 | $109,616.44 | 29,478 |
| 08/18/2025 | DDS | 12 | Direct | COM | $455.82 | $5,469.84 | 29,466 |
| 08/18/2025 | DDS | 329 | Direct | COM | $452.96 | $149,023.84 | 30,262 |
| 08/18/2025 | DDS | 543 | Direct | COM | $454.04 | $246,543.72 | 29,719 |
| 03/03/2025 | DDS | 142 | Direct | COM | $243.36 | $34,557.12 | 28,209 |
| 03/03/2025 | DDS | 96 | Direct | COM | $244.41 | $23,463.36 | 28,113 |
| 03/03/2025 | DDS | 131 | Direct | COM | $242.37 | $31,750.47 | 28,351 |
| 03/03/2025 | DDS | 70 | Direct | COM | $245.26 | $17,168.20 | 28,043 |
| 03/03/2025 | DDS | 3 | Direct | COM | $247.35 | $742.05 | 28,011 |
| 03/03/2025 | DDS | 29 | Direct | COM | $246.18 | $7,139.22 | 28,014 |
| 02/28/2025 | DDS | 23 | Direct | COM | $239.18 | $5,501.14 | 14,785 |
| 02/28/2025 | DDS | 22 | Direct | COM | $238.33 | $5,243.26 | 14,808 |
| 02/28/2025 | DDS | 50 | Direct | COM | $240.32 | $12,016.00 | 14,735 |
| 02/28/2025 | DDS | 28 | Direct | COM | $236.51 | $6,622.28 | 14,830 |
| 02/28/2025 | DDS | 82 | Direct | COM | $241.51 | $19,803.82 | 14,653 |
| 1 2 3 4 Next Last You are at page 1 of 4 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research